Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/53078
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHyun K.-
dc.contributor.authorHollings M.-
dc.contributor.authorBriffa T.-
dc.contributor.authorBrieger D.-
dc.contributor.authorChew D.-
dc.contributor.authorFrench J.-
dc.contributor.authorAstley C.-
dc.contributor.authorGallagher R.-
dc.contributor.authorEllis C.-
dc.contributor.authorCarr B.-
dc.contributor.authorNallaiah K.-
dc.contributor.authorLintern K.-
dc.contributor.authorNeubeck L.-
dc.contributor.authorCandelaria D.-
dc.contributor.authorRedfern J.-
dc.date.accessioned2025-01-20T00:24:59Z-
dc.date.available2025-01-20T00:24:59Z-
dc.date.copyright2024-
dc.date.issued2025-01-13en
dc.identifier.citationEuropean Heart Journal. Conference: European Society of Cardiology Congress, ESC 2024. London United Kingdom. 45(Supplement 1) (no pagination), 2024. Date of Publication: 01 Oct 2024.-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/53078-
dc.description.abstractBackground: In international guidelines, cardiac rehabilitation is recommended to reduce readmissions, mortality and improve disease management. However, evidence from a long-term follow-up in a representative cohort is scarce. Purpose(s): To compare 3-year outcomes among acute coronary syndrome (ACS) survivors who attended cardiac rehabilitation programs and those who did not. Method(s): This was a follow-up of the SNAPSHOT ACS cohort in 1,920 Australians. Clinical data of those presenting with suspected ACS, hospitalised, discharged alive and followed for 18 months were linked to jurisdictional/national regulatory hospitalisation, mortality and pharmacotherapy records. Outcomes were all-cause and cardiovascular mortality, myocardial infarction (MI) and cardiovascular readmissions. Cox regression was used to analyse all-cause mortality, and Fine and Gray competing risk model for cardiovascular mortality, MI and cardiovascular readmissions, where non-cardiovascular mortality or all-cause mortality were competing events. The models were adjusted for age, sex, discharge diagnosis and coronary revascularisation. Result(s): The cohort was aged 66+/-13.5 years; 60% were male, 31% had a discharge diagnosis of MI, and 490 (26%) attended cardiac rehabilitation. Cardiac rehabilitation attendees more frequently received coronary revascularisation and had a discharge diagnosis of MI during index admission. Attendees were more likely to be men (70% vs 57%, p<0.001) with a family history of coronary disease (43% vs 36%, p=0.008). The prescription of >=3 guideline-indicated medications was higher in cardiac rehabilitation attendees. Compared to those who did not attend cardiac rehabilitation, the hazard of all-cause mortality was lower for the attendees (4.3% vs 8.6%, HR: 0.55, 95% CI: 0.34-0.91), but the hazard of MI and cardiovascular readmissions significantly greater in the attendees (17% vs 8.5%, HR: 1.99, 95% CI: 1.41-2.82; 42% vs 33%, HR: 1.34, 95% CI: 1.10-1.63; respectively) (Figure). There was insufficient cardiovascular mortality between groups to fit a statistical model (n=7 (1.4%) vs n=24 (1.7%), p=0.705). Conclusion(s): Survivors of ACS attending cardiac rehabilitation were associated with reduced all-cause mortality and increased readmissions related to MI and cardiovascular disease at 3 years follow-up. These findings support secondary prevention strategies to mitigate mortality risk after ACS.-
dc.publisherOxford University Press-
dc.relation.ispartofEuropean Heart Journal-
dc.subject.meshacute coronary syndrome-
dc.subject.meshcardiovascular disease-
dc.subject.meshcoronary artery disease-
dc.subject.meshheart infarction-
dc.subject.meshheart muscle revascularization-
dc.subject.meshheart rehabilitation-
dc.titleCardiac rehabilitation attendance and outcomes 3 years after acute coronary syndrome (ACS): linked national data of the snapshot ACS audit.-
dc.typeConference Abstract-
dc.identifier.affiliationCardiology (MonashHeart)-
dc.description.conferencenameEuropean Society of Cardiology Congress, ESC 2024-
dc.description.conferencelocationLondon, United Kingdom-
dc.type.studyortrialObservational study (cohort, case-control, cross sectional, or survey)-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1093/eurheartj/ehae666.2976-
local.date.conferencestart2024-08-30-
dc.identifier.institution(Hyun, Hollings, Gallagher, Candelaria, Redfern) University of Sydney, Faculty of Medicine and Health, Sydney, Australia-
dc.identifier.institution(Briffa) University of Western Australia, School of Population and Global Health, Perth, Australia-
dc.identifier.institution(Brieger) Concord Repatriation General Hospital, Department of Cardiology, Sydney, Australia-
dc.identifier.institution(Chew) Victorian Heart Hospital, Melbourne, Australia-
dc.identifier.institution(French) Liverpool Hospital, Ingham Institute, Univeristy of New South Wales, Sydney, Australia-
dc.identifier.institution(Astley) Uniting SA, Adelaide, Australia-
dc.identifier.institution(Ellis) Auckland Heart Group, Auckland, New Zealand-
dc.identifier.institution(Carr) Agency for Clinical Innovation, Sydney, Australia-
dc.identifier.institution(Nallaiah) George Institute for Global Health, Sydney, Australia-
dc.identifier.institution(Lintern) Liverpool Hospital, Sydney, Australia-
dc.identifier.institution(Neubeck) Edinburgh Napier University, Centre for Cardiovascular Health, Edinburgh, United Kingdom-
local.date.conferenceend2024-09-02-
dc.identifier.affiliationmh(Chew) Victorian Heart Hospital, Melbourne, Australia-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairetypeConference Abstract-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Conferences
Show simple item record

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.